Colin Daniel - 22 Oct 2024 Form 4 Insider Report for Sharecare, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Oct 2024, 06:06:53 UTC
Prior SEC filing
07 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christie J. Miller, Attorney-in-Fact for Reporting Person

Key filing fact

Colin Daniel filed Form 4 for Sharecare, Inc. on 25 Oct 2024.

Key facts

  • This page summarizes Colin Daniel's Form 4 filing for Sharecare, Inc..
  • 6 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 25 Oct 2024, 06:06.

Change

  • Previous filing in this sequence was filed on 07 Oct 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SHCR transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-612,748
Change %
-100%
Price
Shares after
0
Date
22 Oct 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SHCR transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-1,964,480
Change %
-100%
Price
$0.000000
Shares after
0
Date
22 Oct 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,964,480
Exercise price
Footnotes
F2
SHCR transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-195,961
Change %
-100%
Price
$0.000000
Shares after
0
Date
22 Oct 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
195,961
Exercise price
$1.05
Footnotes
F3
SHCR transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-926,357
Change %
-100%
Price
$0.000000
Shares after
0
Date
22 Oct 2024
Ownership
By CB Daniel Enterprises, LLLP
Underlying class
Common Stock
Underlying amount
926,357
Exercise price
$1.45
Footnotes
F3, F4
SHCR transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-356,292
Change %
-100%
Price
$0.000000
Shares after
0
Date
22 Oct 2024
Ownership
By CB Daniel Enterprises, LLLP
Underlying class
Common Stock
Underlying amount
356,292
Exercise price
$1.05
Footnotes
F3, F4
SHCR transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-118,718
Change %
-100%
Price
$0.000000
Shares after
0
Date
22 Oct 2024
Ownership
By CB Daniel Enterprises, LLLP
Underlying class
Common Stock
Underlying amount
118,718
Exercise price
$1.45
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Colin Daniel is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

Pursuant to the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among Sharecare, Inc. ("Sharecare"), Impact Acquiror Inc., a Delaware corporation ("Parent") and Impact Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Sharecare common stock, par value $0.0001 ("Company Common Stock"), reported in this row was converted into the right to receive a cash payment (without interest and subject to applicable taxes) equal to the per share merger consideration of $1.43 (the "Merger Consideration"). As a result of the Merger, Reporting Person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.

Footnote F2

Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into (x) a Contingent Cash Award in an amount in cash equal to (A) 70% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration and (y) a Contingent Unit Award having a capital value at the Effective Time equal to (A) 30% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration.

Footnote F3

Pursuant to the Merger Agreement, each outstanding option to purchase shares of Company Common Stock (a "Company Option") that was vested or vested upon the Effective Time was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of multiplying (A) the number of shares of Company Common Stock subject to the Company Option immediately prior to the Effective Time by (B) the excess, if any of (x) the Merger Consideration over (y) the exercise price per share of Company Common Stock of such Company Option (the "Option Consideration"). In addition, each Company Option (whether vested or unvested and for which the exercise price per Share is equal to or greater than the Merger Consideration) was automatically cancelled at the Effective Time without payment of consideration.

Footnote F4

Reporting Person is the beneficial owner and has sole voting and investment power over the securities reported herein held by this entity.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .